Abstract
The process of virus entry accomplishes the delivery of the viral genetic information into the cell so that replication can take place. Entry of enveloped viruses into mammalian cells requires that the virus attach to the host cell surface through an interaction between an envelope component and a cellular molecule that serves as a receptor. After attachment, the virus must cross the plasma membrane during a phase of the life cycle termed penetration. For enveloped viruses, a fusion reaction occurs between the viral envelope in either the endosomal membrane or the plasma membrane. In simple viral systems that have one or two envelope glycoproteins, generally, a single, specific interaction between a viral protein and a cellular constituent is necessary and sufficient to result in infection. The herpesviruses, including human cytomegalovirus (HCMV), are structurally much more complex and often exhibit broad, diverse cellular tropism. Thus, all evidence to date points to the involvement of multiple cellular and viral proteins with overlapping or compensatory mechanisms possibly responsible for entry into specialized cell types.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chee, M. S., et al. (1990) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154, 125ā169.
Gretch, D. R., Kari, B., Rasmussen, L., Gehrz, R. C., and Stinski, M. F. (1988) Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus. J. Virol. 62, 875ā881.
Gretch, D. R., Gehrz, R. C., and Stinski, M. F. (1988) Characterization of a human cytomegalovirus glycoprotein complex (gcI). J. Gen. Virol. 69, 1205ā1215.
Kari, B. and Gehrz, R. (1988) Isolation and characterization of a human cytomegalovirus glycoprotein containing a high content of O-linked oligosaccharides. Arch. Virol. 98, 171ā188.
Cranage, M. P., et al. (1986) Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J. 5, 3057ā3063.
Britt, W. J. and Vugler, L. G. (1992) Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55ā116). J. Virol. 66, 6747ā6754.
Kari, B., Goertz, R., and Gehrz, R. (1990) Characterization of cytomegalovirus glycoproteins in a family of complexes designated gC-II with murine monoclonal antibodies. Arch. Virol. 112, 55ā65.
Britt, W. J. (1984) Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135, 369ā378.
Pereira, L., Hoffman, M., Tatsuno, M., and Dondero, D. (1984) Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology 139, 73ā86.
Rasmussen, L., Mullenax, J., Nelson, R., and Merigan, T. (1985) Viral polypeptides detected by a complement dependent neutralizing murine monoclonal antibody to human cytomegalovirus. J. Virol. 55, 274ā280.
Rasmussen, L., Nelson, R., Kelsall, D., and Merigan, T. (1984) Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 81, 876ā880.
Cranage, M. P., Smith, G. L., Bell, S. E., Hart, H., Brown, C., Bankier, A. T., Tomlinson, P., Barrell, B. G., and Minson, T. C. (1988) Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H. J. Virol. 62, 1416ā1422.
Kaye, J. F., Gompels, U. A., and Minson, A. C. (1992) Glycoprotein H of human cytomegalvirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol. 73, 2693ā2698.
Spaete, R. R., Perot, K., Scott, P. I., Nelson, J. A., Stinski, M. F., and Pachl, C. (1993) Coexpression of truncated human cytomegalovirus GH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology 193, 853ā861.
Huber, M. T. and Compton, T. (1997) Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex. J. Virol. 71, 5391ā5398.
Kari, B., Liu, Y. N., Goertz, R., Lussenhop, N., Stinski, M. F., and Gehrz, R. (1990) Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB). J. Gen. Virol. 71, 2673ā2680.
Kari, B., Li, W., Cooper, J., Goertz, R., and Radeke, B. (1994) The unman cytomegalovirus UL100 gene encodes the GC-II glycoproteins recognized by Group 2 monoclonal antibodies. J. Gen. Virol. 75, 3081ā3086.
Cha, T.-A., Tom, E., Kemble, G. W., Duke, G. M., Mocarski, E. S., and Spaete, R. R. (1996) Human cytomegalovirus clinical isolates carry at least 19 gene not found in laboratory strains. J. Virol. 70, 78ā83.
Neyts, J., Snoeck, R., Schols, D., Balzarini, J., Esko, J. D., Van, S. A., and De, C. E. (1992) Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 189, 48ā58.
Compton, T., Nowlin, D. M., and Cooper, N. R. (1993) Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193, 834ā841.
Boyle, K. A. and Compton, T. (1997) Receptor binding properties of a soluble form of the glycoprotein B of human cytomegalovirus.
Kari, B. and Gehrz, R. (1992) A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J. Virol. 66, 1761ā1764.
Nowlin, D. M., Cooper, N. R., and Compton, T. (1991) Expression of a human cytomegalovirus receptor correlates with infectibility of cells. J. Virol. 65, 3114ā3121.
Wright, J. F., Kurosky, A., and Wasi, S. (1994) An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem. Biophys. Res. Commun. 198, 983ā989.
Pietropaolo, R. and Compton, T. (1997) Cellular annexin II is not required for entry of human cytomegalovirus into fibroblast cells.
Pietropaolo, R. and Compton, T. (1997) Direct interaction between human cytomegalovirus glycoprotein B and cellular annexin II. J. Virol. in press.
Soderberg, C., Giugni, T. D., Zaia, J. A., Larsson, S., Wahlberg, J. M., and Moller, E. (1993) CD13 (human aminopeptidase-N) mediates human cytomegalovirus infection. J. Virol. 67, 6576ā6585.
Compton, T., Nepomuceno, R. R., and Nowlin, D. M. (1992) Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191, 387ā395.
Keay, S. and Baldwin, B. (1992) The human fibroblast receptor for gp86 of human cytomegalovirus is a phosphorylated glycoprotein. J. Virol. 66, 4834ā4838.
Keay, S. and Baldwin, B. (1991) Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment. J. Virol. 65, 5124ā5128.
Bogner, E., Reschke, M., Reis, B., Reis, E., Britt, W., and Radsak, K. (1992) Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus. Arch. Virol. 126, 67ā80.
Stinski, M. F. (1990) Cytomegalovirus and its replication, in Virology (Fields, B. N., Knipe, D. M., et. al., eds.), Raven Press, New York, pp. 1959ā1980.
Montgomery, R. I., Warner, M. S., Lum, B. J., and Spear, P. G. (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427ā436.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Compton, T. (2000). Analysis of Cytomegalovirus Ligands, Receptors, and the Entry Pathway. In: Sinclair, J. (eds) Cytomegalovirus Protocols. Methods in Molecular Medicineā¢, vol 33. Humana Press. https://doi.org/10.1385/1-59259-244-9:53
Download citation
DOI: https://doi.org/10.1385/1-59259-244-9:53
Publisher Name: Humana Press
Print ISBN: 978-0-89603-749-6
Online ISBN: 978-1-59259-244-9
eBook Packages: Springer Protocols